CG
Column Group Portfolio holdings
AUM
$65.7M
This Quarter Return
+0.52%
1 Year Return
-5.8%
3 Year Return
-15.66%
5 Year Return
–
10 Year Return
–
AUM
$452M
AUM Growth
+$452M
(-3.8%)
Cap. Flow
+$3.6M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Revolution Medicines
RVMD
|
$3.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $237M | 52.51% |
18,136,735
| – | – |
|
|
2
Revolution Medicines
RVMD
$7.1B
| $90.3M | 19.98% |
4,577,840
+182,790
| +4% | +$3.6M |
|
3
RAPT Therapeutics
RAPT
$188M
| $64.5M | 14.27% |
2,680,458
| – | – |
|
4
Tenaya Therapeutics
TNYA
$184M
| $27.3M | 6.03% |
9,400,290
| – | – |
|
5
Surrozen
SRZN
$104M
| $18.7M | 4.13% |
9,248,129
| – | – |
|
6
Oric Pharmaceuticals
ORIC
$994M
| $11.4M | 2.53% |
3,568,181
| – | – |
|
|
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $2.47M | 0.55% |
4,309,329
| – | – |
|